Olema Pharmaceuticals, Inc. Earnings Per Share, Basic in USD/shares from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Olema Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to Q3 2025.
  • Olema Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2025 was -0.49 USD/shares, a 18.3% increase year-over-year.
  • Olema Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2025 was -1 USD/shares, a 14.3% increase year-over-year.
  • Olema Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -2.2 USD/shares, a 2.8% decline from 2023.
  • Olema Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -2.14 USD/shares, a 18.3% increase from 2022.
  • Olema Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -2.62 USD/shares, a 45.6% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)

Olema Pharmaceuticals, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 +$0.11 +18.3% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 -$1 -$1 +$0.03 +5.56% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 -$2 $0 +$0.20 +35.7% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 -$2 -$1 $0 -6.38% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-18
Q3 2024 -$2 -$1 $0 -25% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 -$2 -$1 $0 -10.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 -$2 -$1 +$0.14 +20% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 -$2 $0 +$0.18 +27.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-18
Q3 2023 -$2 $0 +$0.09 +15.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$2 $0 +$0.33 +40.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$2 -$1 $0 -20.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$2 -$1 $0 -20.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$2 -$1 $0 -26.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$2 -$1 $0 -95.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1 -$1 $0 -48.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1 -$1 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $0 +$3.26 +87.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $0 +$0.53 +55.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 -$4 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$1 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10

Olema Pharmaceuticals, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 $0 -2.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 -$2 +$0.48 +18.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 -$3 -$1 -45.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$2 +$1.62 +47.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$3 -$2 -106% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$2 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.